Trial Profile
Phase II multi-centre, double-blind, randomised trial of ustekinumab in adolescents with new-onset type 1 diabetes
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 02 Nov 2023
Price :
$35
*
At a glance
- Drugs Ustekinumab (Primary)
- Indications Type 1 diabetes mellitus
- Focus Pharmacokinetics
- Acronyms USTEK1D; USTEKID
- 06 Oct 2023 Results assessing beta cell (pancreatic islets) function and to find a marker/ a composite of markers that reflect the function/ health of the pancreas in people with T1D presented at the 59th Annual Meeting of the European Association for the Study of Diabetes
- 17 Jun 2021 Status changed from suspended to recruiting.
- 23 Apr 2020 Status changed from recruiting to suspended.